{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:42:31Z","timestamp":1780350151360,"version":"3.54.1"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In a 2013 survey, we reported distinct discrepancies in delivery of tuberculosis (TB) and HIV services in eastern Europe (EE) <jats:italic>vs<\/jats:italic>. western Europe (WE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To verify the differences in TB and HIV services in EE <jats:italic>vs<\/jats:italic>. WE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty\u2010three sites completed a survey in 2018 (EE, 14; WE, nine; 88% response rate). Results were compared across as well as within the two regions. When possible, results were compared with the 2013 survey.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Delivery of healthcare was significantly less integrated in EE: provision of TB and HIV services at one site (36% in EE <jats:italic>vs<\/jats:italic>. 89% in WE; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.034), and continued TB follow\u2010up in one location (42% <jats:italic>vs<\/jats:italic>. 100%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.007). Although access to TB diagnostics, standard TB and HIV drugs was generally good, fewer sites in EE reported unlimited access to rifabutin\/multi\u2010drug\u2010resistant TB (MDR\u2010TB) drugs, HIV integrase inhibitors and opioid substitution therapy (OST). Compared with 2013, routine usage of GeneXpert was more common in EE in 2018 (54% <jats:italic>vs<\/jats:italic>. 92%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.073), as was access to moxifloxacin (46% <jats:italic>vs<\/jats:italic>. 91%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.033), linezolid (31% <jats:italic>vs<\/jats:italic>. 64%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.217), and bedaquiline (0% <jats:italic>vs<\/jats:italic>. 25%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.217). Integration of TB and HIV services (46% <jats:italic>vs<\/jats:italic>. 39%; <jats:italic>P<\/jats:italic>\u00a0=\u00a01.000) and provision of OST to patients with opioid dependency (54% <jats:italic>vs<\/jats:italic>. 46%; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.695) remained unchanged.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Delivery of TB and HIV healthcare, including integration of TB and HIV care and access to MDR\u2010TB drugs, still differs between WE and EE, as well as between individual EE sites.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.13016","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T21:42:20Z","timestamp":1605908540000},"page":"283-293","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Healthcare delivery for HIV\u2010positive people with tuberculosis in Europe"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5438-1513","authenticated-orcid":false,"given":"AK","family":"Bentzon","sequence":"first","affiliation":[{"name":"CHIP (Centre of Excellence for Health, Immunity and Infections) Department of Infectious Disease, Rigshospitalet University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Panteleev","sequence":"additional","affiliation":[{"name":"Department of HIV\/TB TB Hospital 2 St Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Mitsura","sequence":"additional","affiliation":[{"name":"Gomel State Medical University Gomel Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Borodulina","sequence":"additional","affiliation":[{"name":"Department of Phthisiology and Pulmonology Samara State Medical University of Minzdrav of Russia Samara Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Skrahina","sequence":"additional","affiliation":[{"name":"Republican Research and Practical Clinic for Pulmonology Minsk Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Denisova","sequence":"additional","affiliation":[{"name":"Botkin Hospital of Infectious Disease St Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Tetradov","sequence":"additional","affiliation":[{"name":"Dr. Victor Babes Hospital Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Podlasin","sequence":"additional","affiliation":[{"name":"Wojewodski Szpital Zakanzy\/Medical University of Warsaw Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Riekstina","sequence":"additional","affiliation":[{"name":"Clinic of TB and Lung Diseases Riga Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Kancauskiene","sequence":"additional","affiliation":[{"name":"Clinic for Communicable Diseases and AIDS Vilnius Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Paduto","sequence":"additional","affiliation":[{"name":"Gomel Region Clinic for Hygiene Svetlogorsk Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-1122","authenticated-orcid":false,"given":"A","family":"Mocroft","sequence":"additional","affiliation":[{"name":"Department of Infection and Population Health University College London London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Trofimova","sequence":"additional","affiliation":[{"name":"Clinic for Prevention and Control of AIDS Novgorod Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Miller","sequence":"additional","affiliation":[{"name":"Mortimer Market Clinic London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-1612","authenticated-orcid":false,"given":"F","family":"Post","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Grezesczuk","sequence":"additional","affiliation":[{"name":"Medical University Teaching Hospital Bialystok Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JD","family":"Lundgren","sequence":"additional","affiliation":[{"name":"CHIP (Centre of Excellence for Health, Immunity and Infections) Department of Infectious Disease, Rigshospitalet University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Inglot","sequence":"additional","affiliation":[{"name":"Wroclaw University School of Medicine Wroclaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Podlekareva","sequence":"additional","affiliation":[{"name":"CHIP (Centre of Excellence for Health, Immunity and Infections) Department of Infectious Disease, Rigshospitalet University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bolokadze","sequence":"additional","affiliation":[{"name":"Infectious Diseases AIDS and Clinical Immunology Research Clinic Tbilisi Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-1837","authenticated-orcid":false,"given":"O","family":"Kirk","sequence":"additional","affiliation":[{"name":"CHIP (Centre of Excellence for Health, Immunity and Infections) Department of Infectious Disease, Rigshospitalet University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the TB:HIV Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS).UNAIDS Data 2017. Program HIV\/AIDS [Internet]. 2017;1\u2013248. Available at:http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20170720_Data_book_2017_en.pdf."},{"key":"e_1_2_7_3_1","unstructured":"Global tuberculosis report 2018.Geneva World Health Organization 2018[cited 2020 Nov 9]. Available at:https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646\u2010eng.pdf?sequence=1&isAllowed=y."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283326879"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00138712"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00252-0"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12256"},{"key":"e_1_2_7_8_1","volume-title":"Guidelines for the Programmatic Management of Drug\u2010Resistant Tuberculosis: 2011 Update","author":"World Health Organization","year":"2011"},{"key":"e_1_2_7_9_1","volume-title":"WHO Treatment Guidelines for Drug\u2010Resistant Tuberculosis 2016","author":"World Health Organization","year":"2016"},{"key":"e_1_2_7_10_1","unstructured":"CHIP \u2013 Centre of Excellence for Health Immunity and Infections[Internet]. [cited 2019 Jan 2]. Available at:https:\/\/chip.dk\/Studies\/TBHIV\/TBHIV\u2010Study\u2010Group"},{"key":"e_1_2_7_11_1","unstructured":"WHO.Rapid Communication: key changes to treatment of multidrug\u2010 and rifampicin\u2010resistant tuberculosis (MDR\/RR\u2010TB). WHO [Internet]. 2018 [cited 2019 Sep 22]; Available at:https:\/\/www.who.int\/tb\/publications\/2018\/rapid_communications_MDR\/en\/"},{"key":"e_1_2_7_12_1","unstructured":"A Survey on Collaborative TB\/HIV Activities in Countries of the WHO European Region \u2010 AFEW International [Internet]. [cited 2019 Oct 14]. Available at:http:\/\/afew.org\/headlines\/tb\u2010hiv\u2010activities\u2010eng\/."},{"key":"e_1_2_7_13_1","unstructured":"WHO\/Europe.Health services delivery \u2010 Integrated care models: an overview (2016) [Internet]. [cited 2020 Jul 23]. Available at:https:\/\/www.euro.who.int\/en\/health\u2010topics\/Health\u2010systems\/health\u2010services\u2010delivery\/publications\/2016\/integrated\u2010care\u2010models\u2010an\u2010overview\u20102016."},{"key":"e_1_2_7_14_1","first-page":"1","article-title":"Integrated health services \u2013 what and why?","volume":"1","author":"World Health Organization","year":"2008","journal-title":"Tech Br"},{"key":"e_1_2_7_15_1","doi-asserted-by":"crossref","unstructured":"HeyeresM McCalmanJ TseyK KinchinI.The complexity of health service integration: a review of reviews [Internet]. Vol. 4 Frontiers in Public Health. Frontiers Media S. A.; 2016 [cited 2020 Jul 23]. p. 223. Available at: \/pmc\/articles\/PMC5066319\/?report=abstract.","DOI":"10.3389\/fpubh.2016.00223"},{"key":"e_1_2_7_16_1","volume-title":"WHO Policy on Collaborative TB\/HIV Activities: Guidelines for National Programmes and Other Stakeholders","author":"World Health Organization","year":"2012"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.03.001"},{"issue":"5","key":"e_1_2_7_18_1","first-page":"CD003343","article-title":"Directly observed therapy for treating tuberculosis","author":"Karumbi J","year":"2015","journal-title":"Cochrane database Syst Rev"},{"key":"e_1_2_7_19_1","unstructured":"HIV\/AIDS surveillance in Europe 2018\u20132017 data [Internet]. [cited 2019 Sep 23]. Available at:https:\/\/ecdc.europa.eu\/en\/publications\u2010data\/hivaids\u2010surveillance\u2010europe\u20102018\u20102017\u2010data."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.12.014"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60743-X"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/630209"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.09.020"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-016-0087-9"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2017.1300634"},{"key":"e_1_2_7_26_1","unstructured":"WHO.WHO treatment guidelines for rifampicin\u2010 and multidrug\u2010resistant tuberculosis 2018 update. WHO [Internet]. 2018 [cited 2019 Jan 26]; Available at:https:\/\/www.who.int\/tb\/areas\u2010of\u2010work\/drug\u2010resistant\u2010tb\/treatment\/gdg\u2010meeting\u2010mdr\u2010rr\u2010tb\u2010treatment\u20102018\u2010update\/en\/."},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013911"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013607"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014181"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hiv.13016","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:00:11Z","timestamp":1693652411000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.13016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/hiv.13016"],"URL":"https:\/\/doi.org\/10.1111\/hiv.13016","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"2020-10-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}